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PRESENTATION

DISCUSSION (CONT.)

DISCUSSION

A 70-year-old Caucasian male with history of end stage renal

The most common cause of morbidity and mortality in renal

The untreated invasive aspergillosis in our patient may have

disease status-post kidney transplant in 2015 was admitted to

transplant patients are infections and their sequelae, including

lead to ARDS and resistant TTP with subsequent mortality.

the intensive care unit for encephalopathy of unknown

TTP1.

The underlying invasive aspergillosis was most likely present

etiology and jaundice.

TTP is a rare syndrome characterized by microangiopathic

prior to hospitalization and potentially may have been the

Home immunosuppressant include tacrolimus, mycophenolate

hemolytic anemia, thrombocytopenia, fever, central nervous

inciting trigger leading to TTP.

mofetil, and prednisone.

system abnormalities, and renal impairment2.

In our extensive literary search, there has been only one

There are some case series and meta-analyses in literature

reported case of underlying invasive aspergillosis in a patient

pneumonia, severe thrombocytopenia, acute kidney injury,

tacrolimus-induced TTP

with TTP6.

transaminitis, hyperbilirubinemia and hyperammonemia

These has been described as a toxic-dose related mechanism; it is

Patient was started on broad-spectrum antibiotics, high dose

gradual in onset with progressive renal failure within weeks to

methylprednisolone, and lactulose; tacrolimus was held.

months2,3.

He was diagnosed with severe sepsis

secondary to

CONCLUSION
Aspergillosis is a rare entity in patients with non-pulmonary

Day one: Patient was noted to have severe anuric renal failure
and emergent hemodialysis was initiated.
Platelet count and hemoglobin continued to decrease requiring

organ transplant but can be fatal if it goes undetected.
Figure 2: Daily chest x-ray comparison and progression of right
lower lobe localized infiltrate (A) to diffuse bilateral infiltrates (D)

It is important to investigate any and all potential underlying

packed red blood cells and platelet transfusion.
Patient had an incalculable LDH, and severely low haptoglobin.
Peripheral smear revealed schistocytes and nucleated RBCs.

etiologies in patients presenting with TTP.

PRESENTATION (CONT.)

We would like to ask the medical community to consider

Day two: With progressive hypoxemic respiratory failure patient

fungal entities early in immunocompromised patients who are

was intubated.

refractory to antibiotic therapy.

PaO2:FiO2 of 158, suggesting moderate acute respiratory
distress syndrome (ARDS).
Day three: Patient underwent bronchoscopy (PaO2:FiO2 <100);
preliminary gram stain & cultures were negative.
LDH remained incalculable.
Figure 1: Peripheral smear showing scant
thrombocytes, schistocytes (black arrow) and
nucleated red blood cells (white arrow)

Thrombotic thrombocytopenic purpura (TTP) was diagnosed
and plasmapheresis was initiated.

Figure 3: Pulmonary Aspergillosis

Aspergillosis is normal pulmonary flora, but can present as a
pathologic infection in immunocompromised patients4.

Day four: Patient suffered a hypoxemic cardiac arrest, and family

Invasive aspergillosis have been observed in 1.5% of the

opted for comfort care measures.

transplanted renal cases with only 0.4% presenting more than six

2 days post-mortem the fungal culture and histopathology from

months following the transplant4.

the bronchoscopy was positive for aspergillus species.

ARDS with underlying invasive pulmonary aspergillosis is rare
but associated with a higher mortality rate5.
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